Research progress in T-cell lymphoblastic lymphoma
10.3760/cma.j.issn.1673-422X.2012.012.019
- VernacularTitle:T淋巴母细胞淋巴瘤的研究进展
- Author:
Xiaolan LIU
;
Liping SU
- Publication Type:Journal Article
- Keywords:
Lymphoma,T cell;
Prognosis;
Therapy
- From:
Journal of International Oncology
2012;(12):942-944
- CountryChina
- Language:Chinese
-
Abstract:
T-lymphoblastic lymphoma (T-LBL) is a rare form of non-Hodgkin lymphoma (NHL),which is biologically similar to T-acute lymphoblastic leukemia(ALL),and occurs most frequently in childhood and adolescence.T-LBL progresses fast.The treatment of LBL with conventional chemotherapy regimens for NHL has shown relatively low rates of complete remission and of disease-free survival.Now,it is reasonable to treat patients with LBL with the current ALL-type protocols,and hematopoietic stem cell transplantation may yield a more favorable overall survival (OS) in T-LBL patients,especial in relapsed or refractory LBL patients.
